Targeting glucocorticoid receptor to enhance immunotherapy response in triple negative breast cancer
Abstract Background Immune checkpoint blockade (ICB) therapies for triple negative breast cancer (TNBC) have yielded limited clinical benefits, which may be attributed to the immunosuppressive tumor immune microenvironment (TIME). Glucocorticoid receptor (GR) has long been thought to suppress immuni...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2026-01-01
|
| Serier: | Breast Cancer Research |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s13058-026-02230-x |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
